DK1697326T3 - Krystalform af en quinolinforbindelse og fremgangsmåde til fremstilling deraf - Google Patents

Krystalform af en quinolinforbindelse og fremgangsmåde til fremstilling deraf

Info

Publication number: DK1697326T3
Authority: DK; Denmark
Prior art keywords: crystal form; preparation; quinoline compound; stability; drug substance
Prior art date: 2003-12-26

Application number

DK04807807.5T

Other languages

English (en)

Inventor

Yoshio Ohara

Yasutaka Takada

Hiroo Matsumoto

Akihiro Yoshida

Original Assignee

Nissan Chemical Ind Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-26

Filing date

2004-12-17

Publication date

2011-09-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34736450&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1697326(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-12-17 Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd

2011-09-19 Application granted granted Critical

2011-09-19 Publication of DK1697326T3 publication Critical patent/DK1697326T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Quinoline Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK04807807.5T 2003-12-26 2004-12-17 Krystalform af en quinolinforbindelse og fremgangsmåde til fremstilling deraf DK1697326T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2003431788		2003-12-26
PCT/JP2004/019451 WO2005063711A1 (en)	2003-12-26	2004-12-17	Crystal form of quinoline compound and process for its production

Publications (1)

Publication Number	Publication Date
DK1697326T3 true DK1697326T3 (da)	2011-09-19

Family

ID=34736450

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04807807.5T DK1697326T3 (da)	2003-12-26	2004-12-17	Krystalform af en quinolinforbindelse og fremgangsmåde til fremstilling deraf

Country Status (21)

Country	Link
US (19)	US20070112024A1 (da)
EP (1)	EP1697326B1 (da)
JP (7)	JP5186108B2 (da)
KR (11)	KR20200015826A (da)
CN (2)	CN1898211A (da)
AT (1)	ATE518835T1 (da)
AU (2)	AU2004309241A1 (da)
CA (1)	CA2551050C (da)
CY (1)	CY1112464T1 (da)
DK (1)	DK1697326T3 (da)
ES (1)	ES2367172T3 (da)
IL (1)	IL176470A (da)
MX (1)	MX338019B (da)
NZ (1)	NZ548041A (da)
PL (1)	PL1697326T3 (da)
PT (1)	PT1697326E (da)
RU (1)	RU2370489C2 (da)
SI (1)	SI1697326T1 (da)
TW (1)	TWI328006B (da)
WO (1)	WO2005063711A1 (da)
ZA (1)	ZA200605658B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3299359A1 (en)	2003-02-12	2018-03-28	Nissan Chemical Industries, Ltd.	Crystalline and amorphous forms of pitavastatin hemicalcium salt
TWI328006B (en)	2003-12-26	2010-08-01	Nissan Chemical Ind Ltd	Crystal form of quinoline compound and process for its production
US7801272B2 (en) *	2007-09-28	2010-09-21	Rigaku Corporation	X-ray diffraction apparatus and X-ray diffraction method
WO2011089623A2 (en)	2010-01-20	2011-07-28	Cadila Healthcare Limited	Process for preparing pitavastatin and pharmaceutically acceptable salts thereof
KR101158517B1 (ko)	2010-04-29	2012-06-21	동방에프티엘(주)	고 순도 피타바스타틴 칼슘염 결정형 ａ의 제조방법
US9034901B2 (en)	2010-08-25	2015-05-19	Cadila Healthcare Limited	Pitavastatin calcium and process for its preparation
EP2638013A4 (en)	2010-11-12	2014-03-26	Hetero Research Foundation	NEW POLYMORPHS OF CALCIUM PIVASTATIN
RU2452939C1 (ru) *	2011-01-18	2012-06-10	Закрытое акционерное общество "Научные приборы"	Рентгенодифракционный способ идентификации партий фармацевтической продукции
ITMI20111475A1 (it) *	2011-08-02	2013-02-03	Dipharma Francis Srl	Forme cristalline di pitavastatina sale di calcio
ES2620968T3 (es)	2011-09-12	2017-06-30	Farma Grs, D.O.O.	Forma polimórfica de pitavastatina cálcica
WO2013098773A1 (en) *	2011-12-28	2013-07-04	Dr. Reddy's Laboratories Limited	Crystalline forms of pitavastatin calcium
KR101461841B1 (ko)	2012-08-08	2014-11-13	코와 가부시키가이샤	의약
IN2015DN03012A (da) *	2012-09-27	2015-10-02	Nissan Chemical Ind Ltd
JP2014034574A (ja) *	2013-01-25	2014-02-24	Kowa Company Ltd	医薬
BR112015022849B1 (pt) *	2013-03-15	2020-02-18	Asieris Pharmaceutical Technologies Co., Ltd.	Sais de adição de base de nitroxolina, usos e processo para preparação dos mesmos, bem como seu cristal, composição farmacêutica e processo para preparação da mesma
CN105213319A (zh) *	2015-09-17	2016-01-06	青岛华之草医药科技有限公司	一种降血脂药物匹伐他汀钙组合物干混悬剂
JP2016222714A (ja) *	2016-09-20	2016-12-28	興和株式会社	医薬
WO2021181360A1 (en) *	2020-03-13	2021-09-16	Cadila Healthcare Limited	Novel salts of quinolone compounds
US20240300899A1 (en) *	2021-03-19	2024-09-12	Zydus Lifesciences Limited	A quinolone compound in solid forms and processes for the preparation thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3175944A (en) *	1956-06-18	1965-03-30	Upjohn Co	Dihydronovobiocin and derivatives thereof
IL63968A (en)	1980-10-01	1985-10-31	Glaxo Group Ltd	Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
GB8320521D0 (en) *	1983-07-29	1983-09-01	Glaxo Group Ltd	Chemical process
JPS61171460A (ja) *	1985-01-23	1986-08-02	Dainippon Pharmaceut Co Ltd	塩酸メクロフエノキサ−ト１型結晶の製造法
JP2569746B2 (ja) *	1987-08-20	1997-01-08	日産化学工業株式会社	キノリン系メバロノラクトン類
JP2877366B2 (ja)	1988-08-25	1999-03-31	協和醗酵工業株式会社	結晶状ｌ−アスコルビン酸−２−リン酸ナトリウム塩の製造法
JP3528186B2 (ja) *	1991-06-24	2004-05-17	日産化学工業株式会社	光学活性キノリンメバロン酸のジアステレオマー塩
JPH0613526A (ja)	1992-06-25	1994-01-21	Seiko Epson Corp	半導体装置用リードフレーム及びその製造方法
JP2575590B2 (ja) *	1992-07-31	1997-01-29	塩野義製薬株式会社	トリアゾリルチオメチルチオセファロスポリン塩酸塩およびその水和物結晶ならびにそれらの製法
FR2694558B1 (fr)	1992-08-05	1994-10-28	Sanofi Elf	Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.
DE4235133A1 (de)	1992-10-19	1994-04-21	Bayer Ag	Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
JP3623531B2 (ja)	1993-06-07	2005-02-23	ビーエーエスエフアクチェンゲゼルシャフト	結晶質ｌ−アスコルビン酸−２−燐酸エステルマグネシウム塩の製造法
JP3558684B2 (ja) *	1994-06-28	2004-08-25	塩野義製薬株式会社	ピロリジルチオカルバペネム誘導体の乾燥方法
CZ20012357A3 (cs) *	1999-01-14	2001-09-12	Nissan Chemical Industries, Ltd.	Způsob přípravy chinolinkarbaldehydu
IL160077A0 (en) *	2001-08-16	2004-06-20	Teva Pharma	Processes for preparing calcium salt forms of statins
US6835838B2 (en)	2002-01-28	2004-12-28	Novartis Ag	Process for the manufacture of organic compounds
DE60326819D1 (de) *	2002-01-31	2009-05-07	Novartis Ag	Verfahren zur herstellung von inhibitoren der hmg-coa-reduktase
US6869970B2 (en) *	2002-02-04	2005-03-22	Novartis Ag	Crystalline salt forms of valsartan
US20050130978A1 (en) *	2002-04-17	2005-06-16	Masamichi Yuda	Novel crystal of quinoxalinedione derivative anhydride
EP3299359A1 (en) *	2003-02-12	2018-03-28	Nissan Chemical Industries, Ltd.	Crystalline and amorphous forms of pitavastatin hemicalcium salt
TWI328006B (en)	2003-12-26	2010-08-01	Nissan Chemical Ind Ltd	Crystal form of quinoline compound and process for its production

2004
- 2004-11-29 TW TW093136780A patent/TWI328006B/zh not_active IP Right Cessation
- 2004-12-17 SI SI200431760T patent/SI1697326T1/sl unknown
- 2004-12-17 KR KR1020207003201A patent/KR20200015826A/ko not_active Withdrawn
- 2004-12-17 ES ES04807807T patent/ES2367172T3/es not_active Expired - Lifetime
- 2004-12-17 KR KR1020187035028A patent/KR20180132973A/ko not_active Withdrawn
- 2004-12-17 PT PT04807807T patent/PT1697326E/pt unknown
- 2004-12-17 CA CA2551050A patent/CA2551050C/en not_active Expired - Lifetime
- 2004-12-17 DK DK04807807.5T patent/DK1697326T3/da active
- 2004-12-17 KR KR1020117002847A patent/KR20110017936A/ko not_active Ceased
- 2004-12-17 KR KR1020177001565A patent/KR20170010111A/ko not_active Withdrawn
- 2004-12-17 KR KR1020167016139A patent/KR20160075844A/ko not_active Withdrawn
- 2004-12-17 WO PCT/JP2004/019451 patent/WO2005063711A1/en not_active Ceased
- 2004-12-17 KR KR1020067011877A patent/KR20070001910A/ko not_active Ceased
- 2004-12-17 CN CNA2004800389550A patent/CN1898211A/zh active Pending
- 2004-12-17 KR KR1020187010082A patent/KR20180040732A/ko not_active Withdrawn
- 2004-12-17 MX MX2011007418A patent/MX338019B/es unknown
- 2004-12-17 JP JP2006520594A patent/JP5186108B2/ja not_active Expired - Lifetime
- 2004-12-17 AT AT04807807T patent/ATE518835T1/de active
- 2004-12-17 CN CN201110198613.7A patent/CN102321019B/zh not_active Expired - Lifetime
- 2004-12-17 KR KR1020207032499A patent/KR20200130510A/ko not_active Ceased
- 2004-12-17 KR KR1020177023135A patent/KR20170098976A/ko not_active Withdrawn
- 2004-12-17 KR KR1020137001739A patent/KR20130014643A/ko not_active Withdrawn
- 2004-12-17 PL PL04807807T patent/PL1697326T3/pl unknown
- 2004-12-17 US US10/584,208 patent/US20070112024A1/en not_active Abandoned
- 2004-12-17 RU RU2006127044/04A patent/RU2370489C2/ru not_active Application Discontinuation
- 2004-12-17 NZ NZ548041A patent/NZ548041A/en not_active IP Right Cessation
- 2004-12-17 KR KR1020197019411A patent/KR20190083674A/ko not_active Withdrawn
- 2004-12-17 ZA ZA200605658A patent/ZA200605658B/en unknown
- 2004-12-17 EP EP04807807A patent/EP1697326B1/en not_active Expired - Lifetime
- 2004-12-17 AU AU2004309241A patent/AU2004309241A1/en not_active Abandoned
2006
- 2006-06-21 IL IL176470A patent/IL176470A/en active IP Right Grant
2009
- 2009-03-11 US US12/401,945 patent/US20090176987A1/en not_active Abandoned
2010
- 2010-12-13 US US12/966,102 patent/US20110082298A1/en not_active Abandoned
2011
- 2011-08-18 AU AU2011213742A patent/AU2011213742C1/en not_active Expired
- 2011-09-07 US US13/227,003 patent/US20110319624A1/en not_active Abandoned
- 2011-10-20 CY CY20111100995T patent/CY1112464T1/el unknown
- 2011-11-29 JP JP2011260984A patent/JP5267643B2/ja not_active Expired - Lifetime
2012
- 2012-06-04 US US13/487,289 patent/US20120245200A1/en not_active Abandoned
2013
- 2013-03-15 US US13/832,285 patent/US20130204000A1/en not_active Abandoned
- 2013-04-05 JP JP2013079889A patent/JP2013136640A/ja not_active Withdrawn
- 2013-10-30 US US14/066,762 patent/US20140058109A1/en not_active Abandoned
2014
- 2014-03-21 US US14/221,372 patent/US20140206719A1/en not_active Abandoned
- 2014-08-01 JP JP2014157888A patent/JP2014205719A/ja not_active Withdrawn
2015
- 2015-02-18 US US14/625,046 patent/US20150158816A1/en not_active Abandoned
- 2015-11-16 JP JP2015224264A patent/JP2016029102A/ja not_active Withdrawn
2016
- 2016-09-15 US US15/266,095 patent/US20170226061A1/en not_active Abandoned
- 2016-11-22 JP JP2016227123A patent/JP2017061536A/ja not_active Withdrawn
2017
- 2017-11-15 US US15/813,422 patent/US20180072676A1/en not_active Abandoned
2018
- 2018-01-10 JP JP2018002103A patent/JP2018052988A/ja not_active Withdrawn
- 2018-06-19 US US16/011,870 patent/US20180297956A1/en not_active Abandoned
2019
- 2019-01-24 US US16/256,070 patent/US20190152916A1/en not_active Abandoned
- 2019-08-19 US US16/543,653 patent/US20190367458A1/en not_active Abandoned
2020
- 2020-03-16 US US16/819,317 patent/US20200216395A1/en not_active Abandoned
- 2020-11-05 US US17/090,353 patent/US20210053923A1/en not_active Abandoned
2022
- 2022-02-28 US US17/682,065 patent/US20220177433A1/en not_active Abandoned
2023
- 2023-06-14 US US18/334,683 patent/US20230322679A1/en not_active Abandoned
2024
- 2024-04-17 US US18/637,529 patent/US20240294476A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2011213742A1 (en)	2011-09-08
KR20110017936A (ko)	2011-02-22
WO2005063711A1 (en)	2005-07-14
US20210053923A1 (en)	2021-02-25
KR20200130510A (ko)	2020-11-18
RU2370489C2 (ru)	2009-10-20
US20140058109A1 (en)	2014-02-27
US20220177433A1 (en)	2022-06-09
AU2011213742C1 (en)	2017-04-06
AU2011213742B2 (en)	2014-05-15
JP2007516952A (ja)	2007-06-28
TWI328006B (en)	2010-08-01
EP1697326B1 (en)	2011-08-03
US20090176987A1 (en)	2009-07-09
US20240294476A1 (en)	2024-09-05
PL1697326T3 (pl)	2011-12-30
US20170226061A1 (en)	2017-08-10
ZA200605658B (en)	2007-11-28
CN102321019B (zh)	2016-06-08
KR20200015826A (ko)	2020-02-12
JP5186108B2 (ja)	2013-04-17
EP1697326A1 (en)	2006-09-06
IL176470A (en)	2011-10-31
US20230322679A1 (en)	2023-10-12
JP2017061536A (ja)	2017-03-30
JP2018052988A (ja)	2018-04-05
KR20160075844A (ko)	2016-06-29
KR20190083674A (ko)	2019-07-12
JP2012072175A (ja)	2012-04-12
KR20180132973A (ko)	2018-12-12
CN1898211A (zh)	2007-01-17
TW200530186A (en)	2005-09-16
KR20170098976A (ko)	2017-08-30
JP2013136640A (ja)	2013-07-11
PT1697326E (pt)	2011-09-12
KR20180040732A (ko)	2018-04-20
US20120245200A1 (en)	2012-09-27
US20190367458A1 (en)	2019-12-05
US20140206719A1 (en)	2014-07-24
KR20170010111A (ko)	2017-01-25
US20110319624A1 (en)	2011-12-29
RU2006127044A (ru)	2008-02-10
KR20070001910A (ko)	2007-01-04
CA2551050A1 (en)	2005-07-14
JP2016029102A (ja)	2016-03-03
US20130204000A1 (en)	2013-08-08
KR20130014643A (ko)	2013-02-07
CY1112464T1 (el)	2015-12-09
HK1095328A1 (en)	2007-05-04
US20110082298A1 (en)	2011-04-07
US20070112024A1 (en)	2007-05-17
NZ548041A (en)	2010-04-30
ES2367172T3 (es)	2011-10-31
ATE518835T1 (de)	2011-08-15
JP5267643B2 (ja)	2013-08-21
IL176470A0 (en)	2006-10-05
US20150158816A1 (en)	2015-06-11
US20200216395A1 (en)	2020-07-09
US20190152916A1 (en)	2019-05-23
US20180072676A1 (en)	2018-03-15
JP2014205719A (ja)	2014-10-30
CN102321019A (zh)	2012-01-18
US20180297956A1 (en)	2018-10-18
CA2551050C (en)	2020-06-02
AU2004309241A1 (en)	2005-07-14
SI1697326T1 (sl)	2011-11-30
MX338019B (es)	2016-03-29

Publication	Publication Date	Title
DK1697326T3 (da)	2011-09-19	Krystalform af en quinolinforbindelse og fremgangsmåde til fremstilling deraf
LU92300I2 (fr)	2013-12-30	Regorafenib et ses sels pharmaceutiquement acceptables (STIVARGA)
EA200900817A1 (ru)	2009-12-30	Способ получения фторметилзамещённых гетероциклических соединений
AP1709A (en)	2007-02-27	Ethanolate of azithromycin, process for manufacure, and pharmaceutical compositions thereof.
EA201990688A1 (ru)	2019-08-30	Полиморфные формы соединения, представляющего собой ингибитор киназ, содержащая их фармацевтическая композиция, способ их получения и их применение
WO2009018065A3 (en)	2009-05-07	Novel glucokinase activators and methods of using same
MX2007006311A (es)	2007-07-11	Acidos hidroxibifenilcarboxilicos y derivados, metodo para producirlos y su uso.
DK1373207T3 (da)	2011-05-30	Nyt amlodipincamsylat og fremgangsmåde til fremstilling heraf
UA88792C2 (ru)	2009-11-25	Гидроксибензоатные соли метаникотиновых соединений
DK1751093T3 (da)	2010-12-20	Substituerede cyklohexyleddikesyre-derivater
EA200800502A1 (ru)	2008-06-30	Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения
ATE438617T1 (de)	2009-08-15	Substituierte cyclohexyl-1,4-diamin-derivate
EA200501734A1 (ru)	2006-04-28	Способ получения (4-гидрокси-6-оксотетрагидропиран-2-ил)ацетонитрила и его производных
TW200612959A (en)	2006-05-01	Method for preparing hydroxamic acids
ATE491686T1 (de)	2011-01-15	Amlodipin-gentisat und verfahren zu dessen herstellung
ATE270296T1 (de)	2004-07-15	Verfahren zur herstellung von hochkristallinem natrium cefoperazon
EA200600542A1 (ru)	2006-08-25	Способ для производства thip
DE602005013007D1 (de)	2009-04-09	Verfahren zur herstellung von lactonen
NO20054418L (no)	2005-09-23	Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse
MX2022006569A (es)	2022-07-01	Proceso para la sintesis de una 2-tioalquilpirimidina.
TH65779A (th)	2004-12-23	กระบวนการเตรียมแพคลิแทคเซล ไทรไฮเดรท และโดซีแทคเซล ไทรไฮเดรท
DE50107619D1 (de)	2006-02-16	Verfahren zur herstellung von 4-brom-anilin-derivaten
RU2004135775A (ru)	2006-05-10	Способ регулирования проницаемости пласта